CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 93 enrolled
Drug / intervention
Test Mealother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01333436
NCT01333436N/ACompleted
CompareCT.gov

A Multicenter, Cross-sectional Study to Evaluate Plasma ApoB-48 Concentration Among Korean Diabetic Patients (With Normal to Moderately High LDL-C Levels)

Organon and Co·interventional·Posted Apr 12, 2011·Updated May 13, 2024

In Brief

A clinical study evaluating Test Meal for Dyslipidemia and Hypercholesterolemia. Completed, enrolled 93 participants across 1 site.

Detailed Summary

This study will evaluate whether fasting/postprandial serum ApoB-48 levels are increased in diabetic participants compared to nondiabetic participants with the same range of serum LDL-C levels, and whether ApoB-48 levels can be used, along with LDL-C levels, to identify potential cardiovascular disease risk.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDyslipidemia, Hypercholesterolemia
CountriesSouth Korea
Collaborators--

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedApr 12, 2011
Enrollment StartJul 20, 2011
Primary CompletionMay 12, 2012
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 15.2 years ago

Interventions

Test Mealother

During Visit 2, a test meal will be supplied by the Sponsor of approximately 944 kcal (57% fat, 31% carbohydrate, and 12% protein), and postprandial blood draws will be done at 1, 2, 3, 4, and 6 hours after the meal.